R&D
Introducing our business areas and technologies.
Collaboration
Universitatsmedizin Mannheim
Theodor-Kutzer-Ufer 1-3 Building No. 24, Level 4 D-68167 Mannheim Tel: 49 621/383-71100
https://www.umm.de
Luxembourg Institute of Health
29, rue Henri Koch L-4354 Esch-sur-Alzette LUXEMBOURG Tel: 352 26 9701
https://www.lih.lu/page/find-us
Hopitaux Robert Schuman
5, rue Edward Steichen L-2540 LUXEMBOURG Tel: 352 26 3331
https://www.hopitauxschuman.lu/fr/
University of California San Francisco
Head & Neck cancer and Colon cancer
chemoradiotherapy correlation between
MBD 3D drug screening system with clinical
1001 Potrero Ave, San Francisco, CA USA 94110 Phone: (415) 282-1149
https://www.ucsf.edu/
Cleveland State University
MBD 3D chip-based hepatotoxicity assay development
2121 Euclid Ave, Cleveland, OH USA 44115 Phone: (216) 687-2000
https://www.csuohio.edu/
Rensselaer Polytechnic Institute
MBD 3D chip based platform research
Antibody & immune cell based Immunoassay chip development
110 Eighth Street, Troy, NY USA 12180 Phone: (518) 276-6000
https://www.rpi.edu/
MBD Co., Ltd.
Medical & Bio Decisioin
C-704, 145, Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea Call. +82-31-888-9381
https://www.mbdbiotech.com/
Domestic Network
Breast Cancer Investigator Initiated Trials
Neoadjuvant Therapy
3D Cancer drug sensitivity testing & Clinical correlation identification
Head and Neck Cancer, Esophageal Cancer Investigator Initiated Trials
Radio-sensitivity Test
Radiation sensitivity test & Clinical correlation identification
Colorectal Cancer Investigator Initiated Trials
Chemo & Antibody based-sensitivity Test
3D Cancer drug sensitivity testing & Clinical correlation identification
Breast Cancer Investigator Initiated Trials
Neoadjuvant Therapy
3D Cancer drug sensitivity testing & Clinical correlation identification
Breast Cancer Investigator Initiated Trials
Neoadjuvant Therapy
3D Cancer drug sensitivity testing & Clinical correlation identification
Lung Cancer Investigator Initiated Trials
Chemo & Antibody based-sensitivity Test
3D Cancer drug sensitivity testing & Clinical correlation identification
3D cancer cell culture based drug toxicity screening research
Breast Cancer Investigator Initiated Trials
Neoadjuvant Therapy
3D Cancer drug sensitivity testing & Clinical correlation identification
Gastric Cancer Investigator Initiated Trials
Chemosensitivity testing & Clinical correlation identification
Patient tissue & Primary culture & Organoid & MBD Platform comparison analysis
MBD Platform based metabolic disease new drug screening assay platform development
Autophagy mechanism cancer drug & new drug development collaboration research
Cancer new drug development collaboration research
Joint research on the development of new drugs for metabolic diseases
C.E.O : Bo Sung Ku Tel : +82-31-888-9500 Fax : +82-31-888-9981
Copyright © 2021 MBD www.mbdbiotech.com All Rights Reserved.